Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

miR-27a as an oncogenic microRNA of hepatitis B virus- related hepatocellular carcinoma.

Wu XJ, Li Y, Liu D, Zhao LD, Bai B, Xue MH.

Asian Pac J Cancer Prev. 2013;14(2):885-9.

2.

MicroRNA-30a-3p inhibits tumor proliferation, invasiveness and metastasis and is downregulated in hepatocellular carcinoma.

Wang W, Lin H, Zhou L, Zhu Q, Gao S, Xie H, Liu Z, Xu Z, Wei J, Huang X, Zheng S.

Eur J Surg Oncol. 2014 Nov;40(11):1586-94. doi: 10.1016/j.ejso.2013.11.008. Epub 2013 Nov 19.

PMID:
24290372
3.

MiR-27a promotes hepatocellular carcinoma cell proliferation through suppression of its target gene peroxisome proliferator-activated receptor γ.

Li S, Li J, Fei BY, Shao D, Pan Y, Mo ZH, Sun BZ, Zhang D, Zheng X, Zhang M, Zhang XW, Chen L.

Chin Med J (Engl). 2015 Apr 5;128(7):941-7. doi: 10.4103/0366-6999.154302.

4.

Upregulated in Hepatitis B virus-associated hepatocellular carcinoma cells, miR-331-3p promotes proliferation of hepatocellular carcinoma cells by targeting ING5.

Cao Y, Chen J, Wang D, Peng H, Tan X, Xiong D, Huang A, Tang H.

Oncotarget. 2015 Nov 10;6(35):38093-106. doi: 10.18632/oncotarget.5642.

5.

The miR-545/374a cluster encoded in the Ftx lncRNA is overexpressed in HBV-related hepatocellular carcinoma and promotes tumorigenesis and tumor progression.

Zhao Q, Li T, Qi J, Liu J, Qin C.

PLoS One. 2014 Oct 9;9(10):e109782. doi: 10.1371/journal.pone.0109782. eCollection 2014.

6.

Hepatitis B virus and microRNAs: Complex interactions affecting hepatitis B virus replication and hepatitis B virus-associated diseases.

Lamontagne J, Steel LF, Bouchard MJ.

World J Gastroenterol. 2015 Jun 28;21(24):7375-99. doi: 10.3748/wjg.v21.i24.7375. Review.

7.

MicroRNA-22 is down-regulated in hepatitis B virus-related hepatocellular carcinoma.

Shi C, Xu X.

Biomed Pharmacother. 2013 Jun;67(5):375-80. doi: 10.1016/j.biopha.2013.03.002. Epub 2013 Mar 24.

PMID:
23582783
8.

Suppressive effects of microRNA-16 on the proliferation, invasion and metastasis of hepatocellular carcinoma cells.

Wu WL, Wang WY, Yao WQ, Li GD.

Int J Mol Med. 2015 Dec;36(6):1713-9. doi: 10.3892/ijmm.2015.2379. Epub 2015 Oct 16.

PMID:
26499886
9.

Loss of tumor suppressor miR-126 contributes to the development of hepatitis B virus-related hepatocellular carcinoma metastasis through the upregulation of ADAM9.

Xiang LY, Ou HH, Liu XC, Chen ZJ, Li XH, Huang Y, Yang DH.

Tumour Biol. 2017 Jun;39(6):1010428317709128. doi: 10.1177/1010428317709128.

PMID:
28639884
10.

Functional analysis of miR-181a and Fas involved in hepatitis B virus-related hepatocellular carcinoma pathogenesis.

Zou C, Chen J, Chen K, Wang S, Cao Y, Zhang J, Sheng Y, Huang A, Tang H.

Exp Cell Res. 2015 Feb 15;331(2):352-61. doi: 10.1016/j.yexcr.2014.11.007. Epub 2014 Nov 20.

PMID:
25449696
11.

HBx-induced miR-21 suppresses cell apoptosis in hepatocellular carcinoma by targeting interleukin-12.

Yin D, Wang Y, Sai W, Zhang L, Miao Y, Cao L, Zhai X, Feng X, Yang L.

Oncol Rep. 2016 Oct;36(4):2305-12. doi: 10.3892/or.2016.5026. Epub 2016 Aug 17.

PMID:
27571873
12.

Increased expression of microRNA-31-5p inhibits cell proliferation, migration, and invasion via regulating Sp1 transcription factor in HepG2 hepatocellular carcinoma cell line.

Zhao G, Han C, Zhang Z, Wang L, Xu J.

Biochem Biophys Res Commun. 2017 Aug 19;490(2):371-377. doi: 10.1016/j.bbrc.2017.06.050. Epub 2017 Jun 13.

13.

miR-139 regulates the proliferation and invasion of hepatocellular carcinoma through the WNT/TCF-4 pathway.

Gu W, Li X, Wang J.

Oncol Rep. 2014 Jan;31(1):397-404. doi: 10.3892/or.2013.2831. Epub 2013 Nov 1.

PMID:
24190507
14.

miR-122 inhibits viral replication and cell proliferation in hepatitis B virus-related hepatocellular carcinoma and targets NDRG3.

Fan CG, Wang CM, Tian C, Wang Y, Li L, Sun WS, Li RF, Liu YG.

Oncol Rep. 2011 Nov;26(5):1281-6. doi: 10.3892/or.2011.1375. Epub 2011 Jul 1.

PMID:
21725618
15.

MicroRNA-144 inhibits hepatocellular carcinoma cell proliferation, invasion and migration by targeting ZFX.

Bao H, Li X, Li H, Xing H, Xu B, Zhang X, Liu Z.

J Biosci. 2017 Mar;42(1):103-111.

16.

MiR-1297 promotes apoptosis and inhibits the proliferation and invasion of hepatocellular carcinoma cells by targeting HMGA2.

Liu Y, Liang H, Jiang X.

Int J Mol Med. 2015 Nov;36(5):1345-52. doi: 10.3892/ijmm.2015.2341. Epub 2015 Sep 10.

PMID:
26398017
17.

Upregulation of PP2Ac predicts poor prognosis and contributes to aggressiveness in hepatocellular carcinoma.

Gong SJ, Feng XJ, Song WH, Chen JM, Wang SM, Xing DJ, Zhu MH, Zhang SH, Xu AM.

Cancer Biol Ther. 2016;17(2):151-62. doi: 10.1080/15384047.2015.1121345. Epub 2015 Nov 30.

18.

MicroRNA-133a functions as a tumor suppressor by targeting IGF-1R in hepatocellular carcinoma.

Zhang W, Liu K, Liu S, Ji B, Wang Y, Liu Y.

Tumour Biol. 2015 Dec;36(12):9779-88. doi: 10.1007/s13277-015-3749-8. Epub 2015 Jul 10.

PMID:
26156803
19.

MiR-27a modulates the MDR1/P-glycoprotein expression by inhibiting FZD7/β-catenin pathway in hepatocellular carcinoma cells.

Chen Z, Ma T, Huang C, Zhang L, Lv X, Xu T, Hu T, Li J.

Cell Signal. 2013 Dec;25(12):2693-701. doi: 10.1016/j.cellsig.2013.08.032. Epub 2013 Sep 7.

PMID:
24018051
20.

Downregulation of microRNA-15b by hepatitis B virus X enhances hepatocellular carcinoma proliferation via fucosyltransferase 2-induced Globo H expression.

Wu CS, Yen CJ, Chou RH, Chen JN, Huang WC, Wu CY, Yu YL.

Int J Cancer. 2014 Apr 1;134(7):1638-47. doi: 10.1002/ijc.28501. Epub 2013 Oct 15.

Supplemental Content

Support Center